Pancreatic Cancer Research

ResearcherHokkaido UniversityActive in the last 2 years

Masaki Kuwatani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0265-6068; OpenAlex author ID A5022514902. Sources: OpenAlex.

Their work

Papers
15 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 15

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. A Case With Longitudinal Changes in Apolipoprotein A2 Isoform Indices Associated With CA19-9 and MRI Findings Until Pancreatic Cancer Development. Co-author DOI 10.1111/jgh.70857↗
  3. Co-targeting an AMPK–MAPK axis reprograms fibroblasts and suppresses PDAC Co-author DOI 10.64898/2026.03.16.711738↗
  4. Treatment of Pancreatic Cancer Using Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Combination with Anticancer Chemotherapeutic D… First author DOI 10.3390/cancers17091584↗
  5. Clinical significance of dispersion imaging by shear wave elastography in the treatment and diagnosis of pancreatic cancer. First author DOI 10.1111/jgh.16143↗
  6. Analysis of the Pancreatic Cancer Microbiome Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration-Derived Samples. Co-author DOI 10.1097/mpa.0000000000002028↗
  7. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable … Co-author DOI 10.1136/bmjopen-2020-045698↗
  8. Non-negligible rate of needle tract seeding after endoscopic ultrasound-guided fine-needle aspiration for patients undergoing distal pancreatectomy for pancrea… First author DOI 10.1111/den.13615↗
  9. Clinical Outcomes of Biliary Drainage during a Neoadjuvant Therapy for Pancreatic Cancer: Metal versus Plastic Stents. Co-author DOI 10.5009/gnl18573↗
  10. Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter… Co-author DOI 10.1002/ags3.12272↗
  11. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis. Co-author DOI 10.1016/j.pan.2019.04.007↗
  12. Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis. First author DOI 10.1111/jgh.14088↗
  13. Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer. First author DOI 10.21037/jgo.2017.02.02↗
  14. Is intraductal papillary mucinous neoplasm of the pancreas just a precursor or identical with pancreatic ductal adenocarcinoma? Co-author DOI 10.1038/ajg.2013.468↗
  15. Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer. Co-author DOI 10.1038/bjc.2013.108↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazumichi Kawakubo · 9 shared papers, 2014–2026 · strength 1.20
  2. Naoya Sakamoto · 8 shared papers, 2014–2026 · strength 1.02
  3. Ryo Sugiura · 3 shared papers, 2018–2026 · strength 0.53
  4. Atsushi Masamune · 2 shared papers, 2025–2026 · strength 0.48
  5. Shin Kato · 4 shared papers, 2018–2023 · strength 0.47
  6. Satoshi Hirano · 3 shared papers, 2019–2026 · strength 0.36
  7. Yasuyuki Kawamoto · 3 shared papers, 2017–2026 · strength 0.36
  8. Naoya Sakamoto · 2 shared papers, 2013–2025 · strength 0.34
  9. Ayumi Kashiro · 1 shared paper, 2026 · strength 0.33
  10. Kazufumi Honda · 1 shared paper, 2026 · strength 0.33
  11. Hiroki Yonemura · 1 shared paper, 2025 · strength 0.30
  12. Kazuaki Harada · 2 shared papers, 2022–2026 · strength 0.30
  13. Makoto Yoshida · 3 shared papers, 2019–2021 · strength 0.28
  14. Yunosuke Takishin · 2 shared papers, 2022–2023 · strength 0.28
  15. Akio Katanuma · 2 shared papers, 2020–2021 · strength 0.20
  16. Shintaro Takeuchi · 1 shared paper, 2026 · strength 0.18
  17. Sho Sekiya · 1 shared paper, 2026 · strength 0.18
  18. Junki Fukuda · 1 shared paper, 2026 · strength 0.18
  19. Toshimichi Asano · 1 shared paper, 2026 · strength 0.18
  20. Atsushi Enomoto · 1 shared paper, 2026 · strength 0.18
  21. Ryodai Yamamura · 1 shared paper, 2026 · strength 0.18
  22. Masahiro Sonoshita · 1 shared paper, 2026 · strength 0.18
  23. Tsuyoshi Hayashi · 2 shared papers, 2019–2020 · strength 0.18
  24. Yasutoshi Kimura · 2 shared papers, 2019–2020 · strength 0.18
  25. Toru Nakamura · 2 shared papers, 2019–2020 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.